Fig. 2
From: Access to innovative cancer medicines in a middle-income country - the case of Mexico
Annual quantities of eight essential cancer medicines procured in the public sector (SHI institutions and MoH) in Mexico (2010–2016)
Advertisement
Fig. 2 | Journal of Pharmaceutical Policy and Practice
